Publications by authors named "Raimundo F Bezares"

Claim this Profile
V
Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia.
Valeria J Sarapura Martinez, Brenda Buonincontro, Chiara Cassarino, Juliana Bernatowiez, Ana Colado, Raimundo F Bezares

Front Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Bruton tyrosine kinase inhibitors. What does the oncohematologist and the cardiologist need to know?].
Sergio J Baratta, Augusto Miroli, Julio Pose Cabarcos, Raimundo F Bezares

Medicina (B Aires)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax-resistant CLL cells show a highly activated and proliferative phenotype.
Esteban Enrique Elias, Valeria Judith Sarapura Martinez, Mikele Amondarain, Ana Colado, Gregorio Cordini, Raimundo Fernando Bezares

Cancer Immunol Immunother· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Sensitivity to Venetoclax and Microenvironment Protection in Hairy Cell Leukemia.
Alexia Vereertbrugghen, Ana Colado, Ernesto Gargiulo, Raimundo Fernando Bezares, Horacio Fernández Grecco

Front Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of ibrutinib on neutrophil and γδ T cell functions.
Denise Risnik, Esteban E Elías, Irene Keitelman, Ana Colado, Enrique Podaza, Raimundo Fernando Bezares

Leuk Lymphoma· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia.
Denise Risnik, Ana Colado, Enrique Podaza, María Belén Almejún, Esteban Enrique Elías, Raimundo Fernando Bezares

Cancer Immunol Immunother· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic lymphocytic leukemia cells increase neutrophils survival and promote their differentiation into CD16 CD62L immunosuppressive subset.
Enrique Podaza, Denise Risnik, Ana Colado, Esteban Elías, María Belén Almejún, Raimundo Fernando Bezares

Int J Cancer· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies.
Esteban Enrique Elías, María Belén Almejún, Ana Colado, Gregorio Cordini, Maricef Vergara-Rubio, Raimundo Fernando Bezares

Haematologica· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting the role of interleukin-8 in chronic lymphocytic leukemia.
Denise Risnik, Enrique Podaza, María B Almejún, Ana Colado, Esteban E Elías, Raimundo F Bezares

Sci Rep· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells.
María Belén Almejún, Mercedes Borge, Ana Colado, Esteban Enrique Elías, Enrique Podaza, Raimundo Fernando Bezares

Haematologica· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients.
Ana Colado, María Belén Almejún, Enrique Podaza, Denise Risnik, Carmen Stanganelli, Raimundo Fernando Bezares

Cancer Immunol Immunother· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophils from chronic lymphocytic leukemia patients exhibit an increased capacity to release extracellular traps (NETs).
Enrique Podaza, Florencia Sabbione, Denise Risnik, Mercedes Borge, María B Almejún, Raimundo F Bezares

Cancer Immunol Immunother· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble RANKL production by leukemic cells in a case of chronic lymphocytic leukemia with bone destruction.
Mercedes Borge, María V Delpino, Enrique Podaza, Carmen Stanganelli, Virginia Palau-Nagore, Raimundo F Bezares

Leuk Lymphoma· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia.
Patricia Dos Santos, Julieta Panero, Virginia Palau Nagore, Carmen Stanganelli, Raimundo F Bezares

Tumour Biol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SOX11 expression in chronic lymphocytic leukemia correlates with adverse prognostic markers.
Alejandro Roisman, Carmen Stanganelli, Virginia Palau Nagore, Guillermo Videla Richardson, María Elida Scassa, Raimundo Fernando Bezares

Tumour Biol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surface localization of high-mobility group nucleosome-binding protein 2 on leukemic B cells from patients with chronic lymphocytic leukemia is related to secondary autoimmune hemolytic anemia.
Pablo E Morande, Mercedes Borge, Cecilia Abreu, Jeremías Galletti, Samanta R Zanetti, Raimundo F Bezares

Leuk Lymphoma· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib impairs the phagocytosis of rituximab-coated leukemic cells from chronic lymphocytic leukemia patients by human macrophages.
Mercedes Borge, María Belén Almejún, Enrique Podaza, Ana Colado, Horacio Fernández Grecco, Raimundo F Bezares

Haematologica· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The expression of sphingosine-1 phosphate receptor-1 in chronic lymphocytic leukemia cells is impaired by tumor microenvironmental signals and enhanced by piceatannol and R406.
Mercedes Borge, Federico Remes Lenicov, Paula R Nannini, María M de los Ríos Alicandú, Enrique Podaza, Raimundo F Bezares

J Immunol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural alterations in chronic lymphocytic leukaemia. Cytogenetic and FISH analysis.
Ana Travella, Lorena Ripollés, Anna Aventin, Andrea Rodríguez, Raimundo F Bezares

Hematol Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCL12 is a costimulator for CD4+ T cell activation and proliferation in chronic lymphocytic leukemia patients.
Mercedes Borge, Paula Romina Nannini, Pablo Elías Morande, Carolina Jancic, Alicia Bistmans, Raimundo Fernando Bezares

Cancer Immunol Immunother· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells.
Pablo E Morande, Samanta R Zanetti, Mercedes Borge, Paula Nannini, Carolina Jancic, Raimundo F Bezares

Invest New Drugs· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter study of subcutaneous alemtuzumab administered at reduced dose in patients with fludarabine-relapsed/refractory chronic lymphocytic leukemia: final analysis.
Raimundo Fernando Bezares, German Stemelin, Alicia Diaz, Daniel Argentieri, Emilio Lanari Zubiaur

Leuk Lymphoma· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCR4 expression in a case of cutaneous Richter's transformation of chronic lymphocytic leukemia (CLL) to diffuse large B-cell lymphoma (DLBCL) and in CLL patients with no skin manifestations.
Paula Romina Nannini, Mercedes Borge, Vanesa Carla Mikolaitis, Cecilia Abreu, Pablo Elías Morande, Raimundo Fernando Bezares

Eur J Haematol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk-adapted therapy with three or six cycles of doxorubicin/bleomycin/vinblastine/dacarbazine plus involved-field radiation therapy in Hodgkin lymphoma, based on prognosis at diagnosis and early response: results from the GATLA study.
Santiago Pavlovsky, Claudia Corrado, Miguel A Pavlovsky, María V Prates, Lucía Zoppegno, Raimundo F Bezares

Clin Lymphoma Myeloma Leuk· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCL12-induced chemotaxis is impaired in T cells from patients with ZAP-70-negative chronic lymphocytic leukemia.
Mercedes Borge, Paula Romina Nannini, Jeremías Gastón Galletti, Pablo Elías Morande, Julio Sánchez Avalos, Raimundo Fernando Bezares

Haematologica· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis